Abstract
Introduction:
Peritoneal metastasis (PM) is a frequent condition in patients presenting with gastric cancer, especially in younger patients with advanced tumor stages. Computer tomography (CT) is the most common noninvasive modality for preoperative staging in gastric cancer. However, the challenges of limited CT soft tissue contrast result in poor CT depiction of small peritoneal tumors. The sensitivity for detecting PM remains low. About 16% of PM are undetected. Deep learning belongs to the category of artificial intelligence and has demonstrated amazing results in medical image analyses. So far, there has been no deep learning study based on CT images for the diagnosis of PM in gastric cancer.
We proposed a hypothesis:
CT images in the primary tumor region of gastric cancer had valuable information that could predict occult PM of gastric cancer, which could be extracted effectively through deep learning.
Objective:
To develop a deep learning model for accurate preoperative diagnosis of PM in gastric cancer.
Method:
All patients with gastric cancer were retrospectively enrolled. All patients were initially diagnosed as PM negative by CT and later confirmed as positive through surgery or laparoscopy. The dataset was randomly split into training cohort (70% of all patients) and testing cohort (30% of all patients). To develop deep convolutional neural network (DCNN) models with high generalizability, 5-fold cross-validation and model ensemble were utilized. The area under the receiver operating characteristic curve, sensitivity and specificity were used to evaluate DCNN models on the testing cohort.
Discussion:
This study will help us know whether deep learning can improve the performance of CT in diagnosing PM in gastric cancer.
Keywords: computed tomography, deep learning, gastric cancer, neural networks, peritoneal metastasis, X-ray
1. Introduction
Although it is steadily declining in incidence, gastric cancer (GC) remains one of the most common and deadly tumor in the world. According to GLOBOCAN 2018 data, GC is the 5th most common and the 3rd most deadly cancer.[1] Peritoneal metastasis (PM) is a frequent condition in patients presenting with GC, especially in younger patients with advanced tumor stages.[2] Given the detrimental influence of PC on survival, efforts should be undertaken to further explore the promising results that were obtained in preventing or treating this condition with multimodality strategies.[2] Therefore, detecting noninvasively PM of GC before surgery would be crucial for avoiding unnecessary resection and selecting optimal therapy in clinical practice.[3–8]
CT is the most common noninvasive modality for preoperative staging in GC.[4,6,8–10] Omentum cake, large amounts of ascites, and parietal peritoneal thickening are typical CT features of PM.[11] However, the challenges of limited CT soft tissue contrast result in poor CT depiction of small peritoneal tumors, which are often indistinguishable from adjacent bowel, mesentery, and mucin.[12–14] These features were not present in all patients with PM, the sensitivity for detecting PM remains low.[11,15–17] About 16% of PM are undetected.[18] PM-negative of patients with GC diagnosed by preoperative CT were confirmed with PM during subsequent surgeries or laparoscopies, which is known as occult PM.[11,19] At present, laparoscopy is the most reliable preoperative method to identify clinically occult PM in patients with GC.[4,7–9,12,20] However, laparoscopy is an invasive and costly procedure and is not systematic in clinical practice. Therefore, we should develop better noninvasive methods to diagnose PM beyond conventional imaging.
There are 2 kinds of medical image analysis method that have entered the stage of rapid development: radiomics and deep learning.[21] Recently, several studies have shown that radiomics based on CT can help diagnose PM in GC.[22–24] Deep learning belongs to the category of artificial intelligence and has demonstrated amazing results in medical image analyses, such as detecting diabetic retinopathy in fundus photographs,[25] classifying skin cancer from skin photographs,[26] and detecting metastasis on pathologic images,[27] and so on. So far, there has been no deep learning study based on CT images for the diagnosis of PM in GC.
We proposed a hypothesis: CT images in the primary tumor region of GC had valuable information that could predict occult PM of GC, which could be extracted effectively through deep learning.
2. Participants and methods
2.1. Study aims
The aim of this study is to develop a deep learning model for accurate preoperative diagnosis of PM in GC.
2.2. Study design/setting
This is a single-center, retrospective, cross-sectional clinical study. The CT data from the Surgical Gastric Cancer Patient Registry of West China Hospital (id: WCH-SGCPR-2019-08), all of which were anonymous.
2.3. Study registration
This clinical trial has been registered on the Chinese Clinical Trial Registry (www.chictr.org.cn), and the registration number is ChiCTR1900028437.
2.4. Eligibility criteria (Fig. 1)
The patients with GC underwent surgery or laparoscopic exploration at our hospital from January 2013 to December 2016 were retrospectively collected.
2.4.1. Inclusion criteria
-
(1)
Diagnosed gastric adenocarcinoma by endoscopy-biopsy pathology.
-
(2)
Contrast-enhanced CT within 2 weeks before laparoscopy or surgery in our hospital; laparoscopy or surgery was performed in our hospital.
-
(3)
The venous images (2 mm slice) were used to draw region of interest (ROIs).
-
(4)
No typical PM indications in CT (omental nodules or omental cake, large amount of ascites, irregular thickening with high peritoneal enhancement).
-
(5)
There was no other evidence of distant metastasis, and no other cancers.
-
(6)
Body mass index ≥24.
2.4.2. Exclusion criteria
-
(1)
Previous abdominal surgery.
-
(2)
Previous abdominal malignancies or inflammatory diseases.
-
(3)
Time intervals between CT and laparoscopy or operation longer than 2 weeks.
-
(4)
Poor CT image quality for post-processing due to artifacts.
2.5. Intervention
This study is a retrospective analysis of CT images and deep learning modeling, with no intervention measures for patients.
2.6. Deep learning methods
2.6.1. CT image acquisition and preprocessing
All patients underwent enhanced CT examination within 2 weeks before surgery or laparoscopic exploration.
Portal vein phase CT images were exported to the ITK-SNAP software (version 2.2.0; www.itksnap.org) for manual segmentation. The lesions of GCs were manually recognized by a radiologist with 5 years’ experience in gastroenterology imaging) and confirmed by another abdominal radiologist with 14 years’ experience in gastroenterology imaging). Two radiologists reviewed all slices of a patient and selected 1 slice with the largest tumor area and manually drawn along the margin of the lesion. The gastric lumen and artifacts were carefully avoided. The images with ROIs derived from ITK-SNAP as input were used to construct the deep learning-based model.
2.6.2. Data management
For the development of the deep learning-based model, all patients’ CT images with PM-negative and patients’ CT images with occult PM, were randomly allocated into 1f of 2 cohorts:
-
(1)
the training data cohort contains 70% patients of occult PM and 70% patients of PM-negative, and 5-fold cross-validation was used to optimize the network weight;
-
(2)
the in-house validation data cohort comprising 30% patients of occult PM and 30% patients of PM-negative to evaluate the predictive performance of the deep learning-based model.
2.6.3. Development of the deep learning-based model
In brief, we adopted a deep convolutional neural network with Depthwise Convolution blocks and Fully Connection layer constructing a classifier. This classifier was designed to determine the probability of a patient having an occult PM. For training the model can predict occult PM, we used weighted cross-entropy loss to supervise the model's parameter optimization direction.
Finally, for each input of CT image, the deep learning-based model provided a continuous value between 0 and 1 as the probability of occult PM, and the process is shown in Figure 2.
2.6.4. Evaluation of the deep learning-based model
We get 5 different single models via 5-fold cross-validation. Then, we carry out all 5 models as a vanilla ensemble model, averaging the predicted risk values of the 5 single models. We analyzed the ROC consistency between the Vanilla ensemble model and each single model. Moreover, we selected each single model as the candidate model based on the above analysis results, and then assembled these to obtain our ensemble model. We evaluate the performance of models on the in-house validation cohort.
2.7. Outcome measure
The outcome is the identified potential differences deep learning features between GC without PM group and GC with PM group will be the outcome measures.
2.8. Data collection and management
Data will be processed anonymously, omitting the information that can identify the participant's individual identity. Strict safety and confidentiality measures will be established in the archives of clinical trial institutions.
2.9. Sample size calculation
We calculated the number of patients needed considering the epidemiology of PM in GC; the estimated sample size was at least 109.
2.10. Statistical analysis
The differences of continuous variables were analyzed by the Mann–Whitney U test, and the differences of categorical variables were analyzed by the Chi-square test. The accuracy of the deep learning-based model was assessed with the receiver operating characteristic (ROC) curve and area under the ROC curve. Delong test was used to compare the ROC curves of models. The calibration of the model was assessed using the calibration curves. In addition, sensitivity and specificity for classification were evaluated.
For the deep learning-based model, 2 different probability values were selected as classification thresholds based on the results of the in-house validation cohort: a high sensitivity threshold (75% sensitivity on in-house validation) and a high specificity threshold (75% specificity on in-house validation). Considering the group imbalance in the in-house validation cohort, we used bootstrap (resampled the in-house validation cohort 1000 times) and calculated the 95% confidence interval. Finally, the decision curve was conducted to evaluate our approach usefulness by quantifying the net benefits at different thresholds probabilities.
All these statistical analyses were performed with SPSS 22.0. A 2-tailed P-value less than .05 was considered statistically significant.
2.11. Ethics and dissemination
This retrospective study was approved by the Biomedical Research Ethics Committee of West China Hospital of Sichuan University (No. 2019-1158), and the requirement for informed consent was waived. To protect privacy of participants, all of private information were anonymous. The results will be published in a peer-reviewed journal and will be disseminated electronically and in print regardless of results. The authors report no conflicts of interest.
3. Discussion
In this study, we will develop a deep learning-based model to preoperative identify occult PM in gastric cancer (AGC). The model may provide a preoperative, and easy-to-use tool for occult PM diagnosis, which can help avoid improper clinical management for patients with occult PM or determine optimal candidates for laparoscopy exploration.
A lot of imaging studies have focused on preoperative assessment of the PM status in GCs.[11,15–17,28] CT should be the preferred diagnostic imaging modality for detecting PM because of the robustness of the data, while MRI and positron emission tomography-computed tomography (PET/CT) should be considered second choices, until more consistent information on their diagnostic yield in detecting PM are obtained.[29] However, diagnostic performance of CT varies substantially among previously reported studies and its overall sensitivity is poor.[30] Recently, a few CT radiomics studies focused on PM of GC. Dong et al reported that venous CT radiomics analysis combining both primary tumor and nearby peritoneum had an excellent prediction value of occult PM of AGC.[24] In another study, Liu et al found that venous CT radiomics analysis based on the primary tumor provided valuable information for predicting occult PM in AGC.[23] The repeatability of radiomics results is easily affected by different image acquisition and reconstruction protocols,[31] while deep learning can avoid these disadvantages of radiomics.[32] The classic theory of tumor metastasis is the “seed and soil” theory, which is now widely accepted,[33] and we also agree with it. But, we did not delineate the peritoneal ROIs as Dong et al[24] did, we were skeptical whether a small 2D area of peritoneum near the tumor would represent the “soil” condition. We are more willing to construct a relationship with PM from the characteristics of the primary tumor.
Our study has several limitations. The ROIs were delineated in 1 single slice (2D), which might not be representative of the entire tumor. Meanwhile, development of model may be affected some input of model extracted from 2D versus 3D images. Therefore, 3D analysis of the entire tumor should be further investigated. Moreover, we used the retrospective datasets to develop deep learning model, of which some clinical factors such as serological tumor markers were not initially available on account of incomplete data.
We hope that the deep learning-based model can be an excellent prediction ability of occult PM and may have significant clinical implications on early detection of occult PM for AGC.
Author contributions
Conceptualization: Zixing Huang, Bing Wu.
Data curation: Dan Liu, Xinzu Chen.
Deep learning method: Pengxin Yu, Jiangfen Wu.
Methodology: Zixing Huang, Pengxin Yu.
Resources: Bin Song, Jiankun Hu.
Supervision: Bin Song, Jiankun Hu, Bing Wu.
Writing – original draft: Zixing Huang, Dan Liu, Xinzu Chen.
Writing – review and editing: Zixing Huang, Bin Song, Jiankun Hu, Bing Wu.
Footnotes
Abbreviations: AGC = advanced gastric cancer, DCNN = deep convolutional neural network, GC = gastric cancer, PM = peritoneal metastasis, ROI = region of interest.
How to cite this article: Huang Z, Liu D, Chen X, Yu P, Wu J, Song B, Hu J, Wu B. Retrospective imaging studies of gastric cancer: study protocol clinical trial (SPIRIT Compliant). Medicine. 2020;99:8(e19157).
ZH and DL contributed equally to this study.
This retrospective study was approved by the Biomedical Research Ethics Committee of West China Hospital of Sichuan University (No. 2019-1158), and the requirement for informed consent was waived. This clinical trial has been registered on the Chinese Clinical Trial Registry (www.chictr.org.cn), and the registration number is ChiCTR1900028437. The results will be published in a peer-reviewed journal and will be disseminated electronically and in print regardless of results.
This work was funded by the 1∗3∗5 Project for Disciplines of Excellence, West China Hospital, Sichuan University (No. ZY2017304).
The authors have no conflicts of interest to disclose.
References
- [1].Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424. [DOI] [PubMed] [Google Scholar]
- [2].Thomassen I, van Gestel YR, van Ramshorst B, et al. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer 2014;134:622–8. [DOI] [PubMed] [Google Scholar]
- [3].Kitayama J, Ishigami H, Yamaguchi H, et al. Treatment of patients with peritoneal metastases from gastric cancer. Ann Gastroenterol Surg 2018;2:116–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [4].Wang FH, Shen L, Li J, et al. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer. Cancer Commun (Lond) 2019;39:10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [5].Guner A, Yildirim R. Surgical management of metastatic gastric cancer: moving beyond the guidelines. Transl Gastroenterol Hepatol 2019;4:58. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [6].Coburn N, Cosby R, Klein L, et al. Staging and surgical approaches in gastric cancer: a clinical practice guideline. Curr Oncol 2017;24:324–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [7].Coburn N, Cosby R, Klein L, et al. Staging and surgical approaches in gastric cancer: a systematic review. Cancer Treat Rev 2018;63:104–15. [DOI] [PubMed] [Google Scholar]
- [8].Muro K, Van Cutsem E, Narita Y, et al. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS. Ann Oncol 2019;30:19–33. [DOI] [PubMed] [Google Scholar]
- [9].Guideline Committee of the Korean Gastric Cancer Association (KGCA). Development working group & review panel. Korean Practice guideline for gastric cancer 2018: an evidence-based, multi-disciplinary approach. J Gastric Cancer 2019;19:1–48. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [10].Smyth EC, Verheij M, Allum W, et al. Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2016;27: suppl 5: v38–49. [DOI] [PubMed] [Google Scholar]
- [11].Kim SJ, Kim HH, Kim YH, et al. Peritoneal metastasis: detection with 16- or 64-detector row CT in patients undergoing surgery for gastric cancer. Radiology 2009;253:407–15. [DOI] [PubMed] [Google Scholar]
- [12].Sugarbaker PH. Preoperative assessment of cancer patients with peritoneal metastases for complete cytoreduction. Indian J Surg Oncol 2016;7:295–302. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [13].Koh JL, Yan TD, Glenn D, et al. Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol 2009;16:327–33. [DOI] [PubMed] [Google Scholar]
- [14].Low RN, Barone RM, Lucero J. Comparison of MRI and CT for predicting the peritoneal cancer index (PCI) preoperatively in patients being considered for cytoreductive surgical procedures. Ann Surg Oncol 2015;22:1708–15. [DOI] [PubMed] [Google Scholar]
- [15].Chang DK, Kim JW, Kim BK, et al. Clinical significance of CT-defined minimal ascites in patients with gastric cancer. World J Gastroenterol 2005;11:6587–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [16].Yan TD, Yonemura Y, Morris DL. Surgical strategies for gastric cancer with synchronous peritoneal carcinomatosis. Br J Surg 2007;94:642–3. [DOI] [PubMed] [Google Scholar]
- [17].Yajima K, Kanda T, Ohashi M, et al. Clinical and diagnostic significance of preoperative computed tomography findings of ascites in patients with advanced gastric cancer. Am J Surg 2006;192:185–90. [DOI] [PubMed] [Google Scholar]
- [18].Ajani JA, Bentrem DJ, Besh S, et al. Gastric cancer, version 2.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw 2013;11:531–46. [DOI] [PubMed] [Google Scholar]
- [19].Burbidge S, Mahady K, Naik K. The role of CT and staging laparoscopy in the staging of gastric cancer. Clin Radiol 2013;68:251–5. [DOI] [PubMed] [Google Scholar]
- [20].Ramos RF, Scalon FM, Scalon MM, et al. Staging laparoscopy in gastric cancer to detect peritoneal metastases: a systematic review and meta-analysis. Eur J Surg Oncol 2016;42:1315–21. [DOI] [PubMed] [Google Scholar]
- [21].Parekh VS, Jacobs MA. Deep learning and radiomics in precision medicine. Expert Rev Precis Med Drug Dev 2019;4:59–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [22].Liu S, He J, Liu S, et al. Radiomics analysis using contrast-enhanced CT for preoperative prediction of occult peritoneal metastasis in advanced gastric cancer. Eur Radiol 2019;30:239–46. [DOI] [PubMed] [Google Scholar]
- [23].Kim M, Jeong WK, Lim S, et al. Gastric cancer: development and validation of a CT-based model to predict peritoneal metastasis. Acta Radiol 2019;doi: 10.1177/0284185119882662. [DOI] [PubMed] [Google Scholar]
- [24].Dong D, Tang L, Li ZY, et al. Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer. Ann Oncol 2019;30:431–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [25].Gulshan V, Peng L, Coram M, et al. Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. JAMA 2016;316:2402–10. [DOI] [PubMed] [Google Scholar]
- [26].Brinker TJ, Hekler A, Enk AH, et al. Deep neural networks are superior to dermatologists in melanoma image classification. Eur J Cancer 2019;119:11–7. [DOI] [PubMed] [Google Scholar]
- [27].Ehteshami Bejnordi B, Veta M, Johannes van Diest P, et al. Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer. JAMA 2017;318:2199–210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [28].Kim SH, Choi YH, Kim JW, et al. Clinical significance of computed tomography-detected ascites in gastric cancer patients with peritoneal metastases. Medicine (Baltimore) 2018;97:e9343. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [29].Laghi A, Bellini D, Rengo M, et al. Diagnostic performance of computed tomography and magnetic resonance imaging for detecting peritoneal metastases: systematic review and meta-analysis. Radiol Med 2017;122:1–5. [DOI] [PubMed] [Google Scholar]
- [30].Wang Z, Chen JQ. Imaging in assessing hepatic and peritoneal metastases of gastric cancer: a systematic review. BMC Gastroenterol 2011;11:19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [31].Rizzo S, Botta F, Raimondi S, et al. Radiomics: the facts and the challenges of image analysis. Eur Radiol Exp 2018;2:36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [32].Litjens G, Kooi T, Bejnordi BE, et al. A survey on deep learning in medical image analysis. Med Image Anal 2017;42:60–88. [DOI] [PubMed] [Google Scholar]
- [33].Akhtar M, Haider A, Rashid S, et al. Paget's “seed and soil” theory of cancer metastasis: an idea whose time has come. Adv Anat Pathol 2019;26:69–74. [DOI] [PubMed] [Google Scholar]